Current status of theranostics in prostate cancer

The aim of this review is to report on the current status of prostate-specific membrane antigen (PSMA)-directed theranostics in prostate cancer (PC) patients. The value of (68)Ga-PSMA-directed PET imaging as a diagnostic procedure for primary and recurrent PC as well as the role of evolving PSMA rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgolini, Irene, Decristoforo, Clemens, Haug, Alexander, Fanti, Stefano, Uprimny, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787224/
https://www.ncbi.nlm.nih.gov/pubmed/29282518
http://dx.doi.org/10.1007/s00259-017-3882-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787224/
https://www.ncbi.nlm.nih.gov/pubmed/29282518
http://dx.doi.org/10.1007/s00259-017-3882-2

Ejemplares similares